Evidence map›Paper›PMID 41332650›Full record

ArticlebioRxiv : the preprint server for biology2025

Lipoprotein lipase requires a flexible lid and stable C-terminal, both maintained by ApoC-II peptide binding.

Emma E Lietzke, Mary S Rouse, Dean Oldham, Ziyue Dong, Robert H Eckel, Kayla G Sprenger, Kimberley D Bruce

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Emma E LietzkeDepartment of Chemical and Biological Engineering, University of Colorado Boulder, 3415 Colorado Ave, Boulder, CO 80303.ORCID 0009-0005-5040-418X
Mary S RouseDivision of Endocrinology, Metabolism, and Diabetes, University of Colorado Anschutz Medical Campus, 12605 E. 16th Ave, Aurora, CO 80045.
Dean OldhamDivision of Endocrinology, Metabolism, and Diabetes, University of Colorado Anschutz Medical Campus, 12605 E. 16th Ave, Aurora, CO 80045.
Ziyue DongDepartment of Chemical and Biological Engineering, University of Colorado Boulder, 3415 Colorado Ave, Boulder, CO 80303.
Robert H EckelDivision of Endocrinology, Metabolism, and Diabetes, University of Colorado Anschutz Medical Campus, 12605 E. 16th Ave, Aurora, CO 80045.
Kayla G SprengerDepartment of Chemical and Biological Engineering, University of Colorado Boulder, 3415 Colorado Ave, Boulder, CO 80303.ORCID 0000-0002-7505-7920
Kimberley D BruceDivision of Endocrinology, Metabolism, and Diabetes, University of Colorado Anschutz Medical Campus, 12605 E. 16th Ave, Aurora, CO 80045.

Funding

Targeting Microglial Lipoprotein Lipase in Alzheimer's diseaseR01AG079217 · NIA · UNIVERSITY OF COLORADO DENVER · PI Kimberley D Bruce · 2022 to 2026
$3.0M
Interdisciplinary Bioengineering Research Training in DiabetesT32DK120520 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI Richard KP Benninger, KATHRYN M HASKINS · 2020 to 2026
$1.1M
NIA NIH HHS R01 AG079217NIDDK NIH HHS T32 DK120520
6 · The paper itself

Abstract

Lipoprotein lipase (LPL) is the rate-limiting enzyme responsible for hydrolyzing triglycerides in circulating lipoproteins. Reduced LPL activity contributes to hypertriglyceridemia, a major cardiovascular risk factor. LPL activity is thought to depend on the conformation of the lid domain, the lipid pore, N- and C-terminal domains (NTD, CTD), and stabilization of these domains by endogenous activators such as apolipoprotein C-II (ApoC-II). Despite major clinical significance, the structure-function relationship of LPL's functional domains and cofactors remain incompletely understood. To address this, we performed the longest known (1-μs) molecular dynamics simulations of LPL independently and in complex with an ApoC-II mimetic peptide (ApoC-II-P). For the first time, we show that LPL's flexible lid can adopt multiple orientations, transitioning between open and closed states that regulate lipid pore access and catalytic activity. We also observed 'flipping' of ~180° by the CTD, a unique characteristic that dictates LPL activity when not in a closed lid state. Furthermore, ApoC-II-P stabilizes LPL by bridging its NTD and CTD, while maintaining an optimal lid orientation. Biochemical and cellular assays corroborate these findings, demonstrating that ApoC-II-P enhances LPL hydrolysis and supports noncanonical LPL functions. Together, these insights reveal previously unrecognized mechanisms governing LPL regulation and activity dynamics.

Identifiers

PMID41332650
PMCPMC12667955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.